Publication:

Randomized, controlled clinical two-centre study using xenogeneic block grafts loaded with recombinant human bone morphogenetic protein-2 or autogenous bone blocks for lateral ridge augmentation

Date

Date

Date
2018
Journal Article
Published version
cris.lastimport.scopus2025-08-18T03:42:31Z
cris.lastimport.wos2025-08-17T03:01:50Z
cris.virtual.orcidhttps://orcid.org/0000-0002-1377-0325
cris.virtualsource.orcid187c58f2-3cd9-428f-bb7a-ef8d5cf2f26a
dc.contributor.institutionUniversity of Zurich
dc.date.accessioned2018-01-12T11:43:05Z
dc.date.available2018-01-12T11:43:05Z
dc.date.issued2018-02
dc.description.abstract

OBJECTIVES To test whether or not the use of a xenogeneic block loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) results in different bone quantity and quality compared to an autogenous bone block. MATERIALS AND METHODS Twenty-four patients with insufficient bone volume for implant placement were randomly assigned to two treatment modalities: a xenogeneic bone block loaded with rhBMP-2 (test) and an autogenous bone block (control). The horizontal ridge width was evaluated prior to augmentation, after augmentation and at 4 months. Patient-reported outcome measures (PROMs) were assessed at suture removal and at 4 months. Biopsies were obtained at 4 months and histologically evaluated. Intergroup comparisons were tested by a two-sided Wilcoxon-Mann-Whitney test, intra-group comparisons were performed with Wilcoxon-signed rank test, and all categorical variables were tested with Chi-squared tests. RESULTS One autogenous bone block failed. This patient was replaced, and in all subsequently treated 24 patients, implant placement was possible 4 months later. The median ridge width increased from 4.0 mm (Q1 = 2.0; Q3 = 4.0) (test) and 2.0 mm (Q1 = 2.0; Q3 = 3.0) (control) to 7.0 mm (Q1 = 6.0; Q3 = 8.0) (test) and 7.0 mm (Q1 = 6.0; Q3 = 8.0) (control) at 4 months (intergroup p > .05). A higher morbidity was reported at the augmented site in the control group during surgery. Sensitivity was more favourable in the test than that in the control group at 4 months. The biopsies revealed more mineralized tissue in the control group (p < .0043). CONCLUSIONS Both treatment modalities were successful in regenerating bone to place dental implants. PROMs did not reveal any significant differences between the groups except for pain during surgery at the recipient site (in favour of the test group). Histologically, a higher amount of mineralized tissue was observed for the control group at 4 months.

dc.identifier.doi10.1111/jcpe.12841
dc.identifier.issn0303-6979
dc.identifier.scopus2-s2.0-85038026473
dc.identifier.urihttps://www.zora.uzh.ch/handle/20.500.14742/136686
dc.identifier.wos000419830500012
dc.language.isoeng
dc.subject.ddc610 Medicine & health
dc.title

Randomized, controlled clinical two-centre study using xenogeneic block grafts loaded with recombinant human bone morphogenetic protein-2 or autogenous bone blocks for lateral ridge augmentation

dc.typearticle
dcterms.accessRightsinfo:eu-repo/semantics/openAccess
dcterms.bibliographicCitation.journaltitleJournal of Clinical Periodontology
dcterms.bibliographicCitation.number2
dcterms.bibliographicCitation.originalpublishernameWiley-Blackwell Publishing, Inc.
dcterms.bibliographicCitation.pageend276
dcterms.bibliographicCitation.pagestart265
dcterms.bibliographicCitation.pmid29150957
dcterms.bibliographicCitation.volume45
dspace.entity.typePublicationen
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.affiliationMedizinische Universität Graz
uzh.contributor.affiliationMedizinische Universität Graz
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.affiliationYonsei University College of Dentistry
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.affiliationUniversity of Zurich
uzh.contributor.authorThoma, Daniel S
uzh.contributor.authorPayer, Michael
uzh.contributor.authorJakse, Norbert
uzh.contributor.authorBienz, Stefan P
uzh.contributor.authorHüsler, Jürg
uzh.contributor.authorSchmidlin, Patrick R
uzh.contributor.authorJung, Ui-Won
uzh.contributor.authorHämmerle, Christoph H F
uzh.contributor.authorJung, Ronald E
uzh.contributor.correspondenceYes
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.contributor.correspondenceNo
uzh.document.availabilitypostprint
uzh.eprint.datestamp2018-01-12 11:43:05
uzh.eprint.lastmod2025-08-18 03:42:31
uzh.eprint.statusChange2018-01-12 11:43:05
uzh.harvester.ethYes
uzh.harvester.nbNo
uzh.identifier.doi10.5167/uzh-145039
uzh.jdb.eprintsId13662
uzh.oastatus.unpaywallgreen
uzh.oastatus.zoraGreen
uzh.publication.citationThoma, Daniel S; Payer, Michael; Jakse, Norbert; Bienz, Stefan P; Hüsler, Jürg; Schmidlin, Patrick R; Jung, Ui-Won; Hämmerle, Christoph H F; Jung, Ronald E (2018). Randomized, controlled clinical two-centre study using xenogeneic block grafts loaded with recombinant human bone morphogenetic protein-2 or autogenous bone blocks for lateral ridge augmentation. Journal of Clinical Periodontology, 45(2):265-276.
uzh.publication.originalworkoriginal
uzh.publication.publishedStatusfinal
uzh.scopus.impact39
uzh.scopus.subjectsPeriodontics
uzh.workflow.doajuzh.workflow.doaj.false
uzh.workflow.eprintid145039
uzh.workflow.fulltextStatuspublic
uzh.workflow.revisions53
uzh.workflow.rightsCheckkeininfo
uzh.workflow.sourcePubMed:PMID:29150957
uzh.workflow.statusarchive
uzh.wos.impact40
Files

Original bundle

Name:
60_Schmidlin_StudyXenogenei_JClinPerio_2017.pdf
Size:
224.49 KB
Format:
Adobe Portable Document Format
Publication available in collections: